Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1213 entries
Sorted by: Best Match Show Resources per page
Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels.

Mediterranean journal of hematology and infectious diseases

Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV.
PMID: 28512557
Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017.

OBJECTIVES: To explore the incidence of vaso-occlusive crisis (VOC) in Blood Group "O" sickle cell disease (SCD) patients, and correlate it with the blood group and thrombospondin (TSP) levels.METHODS: In 89 consecutive SCD patients, blood samples were obtained for...

Cite
Al Huneini M, Alkindi S, Panjwani V, et al. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017;9(1):e2017028doi: 10.4084/MJHID.2017.028.
Al Huneini, M., Alkindi, S., Panjwani, V., Al Falahi, K., Al Balushi, B., Gravell, D., Ho, C. H., Krishnamoorthy, R., & Pathare, A. V. (2017). Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterranean journal of hematology and infectious diseases, 9(1), e2017028. https://doi.org/10.4084/MJHID.2017.028
Al Huneini, M, et al. "Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels." Mediterranean journal of hematology and infectious diseases vol. 9,1 (2017): e2017028. doi: https://doi.org/10.4084/MJHID.2017.028
Al Huneini M, Alkindi S, Panjwani V, Al Falahi K, Al Balushi B, Gravell D, Ho CH, Krishnamoorthy R, Pathare AV. Increased Vasoocclusive Crises in "O" Blood Group Sickle Cell Disease Patients: Association with Underlying Thrombospondin Levels. Mediterr J Hematol Infect Dis. 2017 Apr 20;9(1):e2017028. doi: 10.4084/MJHID.2017.028. eCollection 2017. PMID: 28512557; PMCID: PMC5419181.
Copy Download .nbib Format: NLM
Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data.

World journal of emergency surgery : WJES

Burggraf M, Payas A, Kauther MD, Schoeneberg C, Lendemans S.
PMID: 26396589
World J Emerg Surg. 2015 Sep 22;10:43. doi: 10.1186/s13017-015-0038-1. eCollection 2015.

INTRODUCTION: Traumatic injuries are amongst the leading causes of death worldwide, frequently as a result of uncontrolled hemorrhage. Critical deficiencies in clotting factors have been noted in trauma-induced coagulopathy. However, the exact underlying conditions that result in devastating coagulopathies...

Cite
Burggraf M, Payas A, Kauther MD, et al. Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World J Emerg Surg. 2015;10:43doi: 10.1186/s13017-015-0038-1.
Burggraf, M., Payas, A., Kauther, M. D., Schoeneberg, C., & Lendemans, S. (2015). Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World journal of emergency surgery : WJES, 1043. https://doi.org/10.1186/s13017-015-0038-1
Burggraf, Manuel, et al. "Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data." World journal of emergency surgery : WJES vol. 10 (2015): 43. doi: https://doi.org/10.1186/s13017-015-0038-1
Burggraf M, Payas A, Kauther MD, Schoeneberg C, Lendemans S. Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World J Emerg Surg. 2015 Sep 22;10:43. doi: 10.1186/s13017-015-0038-1. eCollection 2015. PMID: 26396589; PMCID: PMC4578761.
Copy Download .nbib Format: NLM
Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq.

Haemophilia : the official journal of the World Federation of Hemophilia

Klukowska A, Szczepański T, Vdovin V, Knaub S, Jansen M, Liesner R.
PMID: 26370328
Haemophilia. 2016 Mar;22(2):232-239. doi: 10.1111/hae.12797. Epub 2015 Sep 14.

INTRODUCTION: NuwiqAIM/METHODS: This prospective, open-label, multinational phase III study assessed the efficacy and safety of Human-cl rhFVIII in 59 previously treated patients (PTPs) with severe haemophilia A aged 2-12 years (2-5 [N = 29]; 6-12 [N = 30]) during...

Cite
Klukowska A, Szczepański T, Vdovin V, et al. Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq. Haemophilia. 2015;22(2):232-239doi: 10.1111/hae.12797.
Klukowska, A., Szczepański, T., Vdovin, V., Knaub, S., Jansen, M., & Liesner, R. (2016). Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq. Haemophilia : the official journal of the World Federation of Hemophilia, 22(2), 232-239. https://doi.org/10.1111/hae.12797
Klukowska, A, et al. "Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq." Haemophilia : the official journal of the World Federation of Hemophilia vol. 22,2 (2016): 232-239. doi: https://doi.org/10.1111/hae.12797
Klukowska A, Szczepański T, Vdovin V, Knaub S, Jansen M, Liesner R. Novel, human cell line-derived recombinant factor VIII (Human-cl rhFVIII, Nuwiq. Haemophilia. 2016 Mar;22(2):232-239. doi: 10.1111/hae.12797. Epub 2015 Sep 14. PMID: 26370328.
Copy Download .nbib Format: NLM
Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma.

Open access Macedonian journal of medical sciences

Badawi MA, Abouelfadl DM, El-Sharkawy SL, El-Aal WE, Abbas NF.
PMID: 27275223
Open Access Maced J Med Sci. 2015 Jun 15;3(2):209-14. doi: 10.3889/oamjms.2015.044. Epub 2015 Apr 27.

AIM: This study aimed to clarify how macrophages affect prognosis in cancer colon and their association with tumor angiogenesis.MATERIAL AND METHODS: Forty four biopsies of colon carcinoma and 15 of benign adenomatous polyps were investigated for macrophages infiltration and...

Cite
Badawi MA, Abouelfadl DM, El-Sharkawy SL, et al. Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma. Open Access Maced J Med Sci. 2015;3(2):209-14doi: 10.3889/oamjms.2015.044.
Badawi, M. A., Abouelfadl, D. M., El-Sharkawy, S. L., El-Aal, W. E., & Abbas, N. F. (2015). Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma. Open access Macedonian journal of medical sciences, 3(2), 209-14. https://doi.org/10.3889/oamjms.2015.044
Badawi, Manal A, et al. "Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma." Open access Macedonian journal of medical sciences vol. 3,2 (2015): 209-14. doi: https://doi.org/10.3889/oamjms.2015.044
Badawi MA, Abouelfadl DM, El-Sharkawy SL, El-Aal WE, Abbas NF. Tumor-Associated Macrophage (TAM) and Angiogenesis in Human Colon Carcinoma. Open Access Maced J Med Sci. 2015 Jun 15;3(2):209-14. doi: 10.3889/oamjms.2015.044. Epub 2015 Apr 27. PMID: 27275223; PMCID: PMC4877855.
Copy Download .nbib Format: NLM
Primary angiosarcoma of the skull: A rare case report.

Surgical neurology international

Chugh AP, Gandhoke CS, Mohite AG, Khedkar BV.
PMID: 25024892
Surg Neurol Int. 2014 Jun 11;5:92. doi: 10.4103/2152-7806.134365. eCollection 2014.

BACKGROUND: Angiosarcomas are rare high grade endothelial tumors characterized by rapidly proliferating anaplastic cells derived from blood vessels and lining irregular blood filled spaces. Primary neoplasms of the skull are rare, representing 2.6% of primary neoplasms of bone. Primary...

Cite
Chugh AP, Gandhoke CS, Mohite AG, et al. Primary angiosarcoma of the skull: A rare case report. Surg Neurol Int. 2014;5:92doi: 10.4103/2152-7806.134365.
Chugh, A. P., Gandhoke, C. S., Mohite, A. G., & Khedkar, B. V. (2014). Primary angiosarcoma of the skull: A rare case report. Surgical neurology international, 592. https://doi.org/10.4103/2152-7806.134365
Chugh, Ashish P, et al. "Primary angiosarcoma of the skull: A rare case report." Surgical neurology international vol. 5 (2014): 92. doi: https://doi.org/10.4103/2152-7806.134365
Chugh AP, Gandhoke CS, Mohite AG, Khedkar BV. Primary angiosarcoma of the skull: A rare case report. Surg Neurol Int. 2014 Jun 11;5:92. doi: 10.4103/2152-7806.134365. eCollection 2014. PMID: 25024892; PMCID: PMC4093732.
Copy Download .nbib Format: NLM
Factors affecting the quality of cryoprecipitate.

Asian journal of transfusion science

Subramaniyan R, Marwaha N, Jain A, Ahluwalia J.
PMID: 28316438
Asian J Transfus Sci. 2017 Jan-Jun;11(1):33-39. doi: 10.4103/0973-6247.200778.

BACKGROUND: Many variables affect the quality of cryoprecipitate (CRYO). We investigated the effect of freezing techniques and ABO blood groups on the quality of CRYO with respect to factor VIII: C and fibrinogen levels.MATERIALS AND METHODS: Ninety-six whole blood...

Cite
Subramaniyan R, Marwaha N, Jain A, et al. Factors affecting the quality of cryoprecipitate. Asian J Transfus Sci. 2017;11(1):33-39doi: 10.4103/0973-6247.200778.
Subramaniyan, R., Marwaha, N., Jain, A., & Ahluwalia, J. (2017). Factors affecting the quality of cryoprecipitate. Asian journal of transfusion science, 11(1), 33-39. https://doi.org/10.4103/0973-6247.200778
Subramaniyan, Rajeswari, et al. "Factors affecting the quality of cryoprecipitate." Asian journal of transfusion science vol. 11,1 (2017): 33-39. doi: https://doi.org/10.4103/0973-6247.200778
Subramaniyan R, Marwaha N, Jain A, Ahluwalia J. Factors affecting the quality of cryoprecipitate. Asian J Transfus Sci. 2017 Jan-Jun;11(1):33-39. doi: 10.4103/0973-6247.200778. PMID: 28316438; PMCID: PMC5345278.
Copy Download .nbib Format: NLM
Successful emergency resection of a massive intra-abdominal hemophilic pseudotumor.

World journal of gastrointestinal surgery

Frezin J, Marique L, Coubeau L, Hubert C, Lambert C, Hermans C, Jabbour N.
PMID: 25848492
World J Gastrointest Surg. 2015 Mar 27;7(3):43-6. doi: 10.4240/wjgs.v7.i3.43.

An intra-abdominal pseudotumor is a rare complication of hemophilia. Surgical treatment is associated with high morbidity and mortality rates and reported cases are scarce. We present a 66-year-old Caucasian male suffering from severe hemophilia type A treated for 10...

Cite
Frezin J, Marique L, Coubeau L, et al. Successful emergency resection of a massive intra-abdominal hemophilic pseudotumor. World J Gastrointest Surg. 2015;7(3):43-6doi: 10.4240/wjgs.v7.i3.43.
Frezin, J., Marique, L., Coubeau, L., Hubert, C., Lambert, C., Hermans, C., & Jabbour, N. (2015). Successful emergency resection of a massive intra-abdominal hemophilic pseudotumor. World journal of gastrointestinal surgery, 7(3), 43-6. https://doi.org/10.4240/wjgs.v7.i3.43
Frezin, Julie, et al. "Successful emergency resection of a massive intra-abdominal hemophilic pseudotumor." World journal of gastrointestinal surgery vol. 7,3 (2015): 43-6. doi: https://doi.org/10.4240/wjgs.v7.i3.43
Frezin J, Marique L, Coubeau L, Hubert C, Lambert C, Hermans C, Jabbour N. Successful emergency resection of a massive intra-abdominal hemophilic pseudotumor. World J Gastrointest Surg. 2015 Mar 27;7(3):43-6. doi: 10.4240/wjgs.v7.i3.43. PMID: 25848492; PMCID: PMC4381156.
Copy Download .nbib Format: NLM
Workshop III: Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis.

Haemophilia : the official journal of the World Federation of Hemophilia

[No authors listed]
PMID: 27213873
Haemophilia. 1997 Dec;3:24-30. doi: 10.1111/j.1365-2516.1997.tb00182.x.

No abstract available.

Cite
Workshop III: Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis. Haemophilia. 1997;3:24-30doi: 10.1111/j.1365-2516.1997.tb00182.x.
(1997). Workshop III: Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia, 324-30. https://doi.org/10.1111/j.1365-2516.1997.tb00182.x
"Workshop III: Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis." Haemophilia : the official journal of the World Federation of Hemophilia vol. 3 (1997): 24-30. doi: https://doi.org/10.1111/j.1365-2516.1997.tb00182.x
Workshop III: Porcine factor VIII: Continuous infusion, immune tolerance induction and prophylaxis. Haemophilia. 1997 Dec;3:24-30. doi: 10.1111/j.1365-2516.1997.tb00182.x. PMID: 27213873.
Copy Download .nbib Format: NLM
Recombinant coagulation factor products.

Haemophilia : the official journal of the World Federation of Hemophilia

Brettler DB.
PMID: 27214531
Haemophilia. 1995 Jul;1(3):155-8. doi: 10.1111/j.1365-2516.1995.tb00059.x.

There are numerous new coagulation factor concentrates that are being manufactured using recombinant technology. Some are available for use currently for the treatment of bleeding disorders and others are in clinical trials. Recombinant factor VIII concentrates are licenced in...

Cite
Brettler DB. Recombinant coagulation factor products. Haemophilia. 1995;1(3):155-8doi: 10.1111/j.1365-2516.1995.tb00059.x.
Brettler, D. B. (1995). Recombinant coagulation factor products. Haemophilia : the official journal of the World Federation of Hemophilia, 1(3), 155-8. https://doi.org/10.1111/j.1365-2516.1995.tb00059.x
Brettler, D B. "Recombinant coagulation factor products." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,3 (1995): 155-8. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00059.x
Brettler DB. Recombinant coagulation factor products. Haemophilia. 1995 Jul;1(3):155-8. doi: 10.1111/j.1365-2516.1995.tb00059.x. PMID: 27214531.
Copy Download .nbib Format: NLM
A new approach to immunologic identification of factor VIII antibodies.

Haemophilia : the official journal of the World Federation of Hemophilia

Shurafa M, Kithier K.
PMID: 27214535
Haemophilia. 1995 Jul;1(3):175-7. doi: 10.1111/j.1365-2516.1995.tb00063.x.

We tested for antibodies against factor VIII by using monoclonal antibody-purified factor VIII preparation as a source of antigen. The factor VIII was adsorbed on nitrocellulose membranes and stored in a refrigerator until later use. Plasma or serum was...

Cite
Shurafa M, Kithier K. A new approach to immunologic identification of factor VIII antibodies. Haemophilia. 1995;1(3):175-7doi: 10.1111/j.1365-2516.1995.tb00063.x.
Shurafa, M., & Kithier, K. (1995). A new approach to immunologic identification of factor VIII antibodies. Haemophilia : the official journal of the World Federation of Hemophilia, 1(3), 175-7. https://doi.org/10.1111/j.1365-2516.1995.tb00063.x
Shurafa, M, and Kithier, K. "A new approach to immunologic identification of factor VIII antibodies." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,3 (1995): 175-7. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00063.x
Shurafa M, Kithier K. A new approach to immunologic identification of factor VIII antibodies. Haemophilia. 1995 Jul;1(3):175-7. doi: 10.1111/j.1365-2516.1995.tb00063.x. PMID: 27214535.
Copy Download .nbib Format: NLM
The impact of prenatal diagnosis on the incidence of haemophilia in Sweden.

Haemophilia : the official journal of the World Federation of Hemophilia

Ljung R, Kling S, Tedgird U.
PMID: 27214538
Haemophilia. 1995 Jul;1(3):190-3. doi: 10.1111/j.1365-2516.1995.tb00066.x.

A demographic survey was made of all children (n= 137) born with severe or moderate haemophilia in Sweden during the period 1970-92. Bn addition, all prenatal diagnoses (n= 86) performing during the period were evaluated. The annual incidence of...

Cite
Ljung R, Kling S, Tedgird U. The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia. 1995;1(3):190-3doi: 10.1111/j.1365-2516.1995.tb00066.x.
Ljung, R., Kling, S., & Tedgird, U. (1995). The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia : the official journal of the World Federation of Hemophilia, 1(3), 190-3. https://doi.org/10.1111/j.1365-2516.1995.tb00066.x
Ljung, R, et al. "The impact of prenatal diagnosis on the incidence of haemophilia in Sweden." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,3 (1995): 190-3. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00066.x
Ljung R, Kling S, Tedgird U. The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia. 1995 Jul;1(3):190-3. doi: 10.1111/j.1365-2516.1995.tb00066.x. PMID: 27214538.
Copy Download .nbib Format: NLM
Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia

Maliekel K, Rana N, Green D.
PMID: 27214621
Haemophilia. 1997 Jan;3(1):54-8. doi: 10.1046/j.1365-2516.1997.00075.x.

Bleeding in nonhaemophilic patients with high-titre factor VIII autoantibodies is often severe, life-threatening and refractory to treatment with factor VIII concentrates. In this report, we describe an elderly woman who required surgical excision of a large haemophilic pseudotumour adjacent...

Cite
Maliekel K, Rana N, Green D. Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia. 1997;3(1):54-8doi: 10.1046/j.1365-2516.1997.00075.x.
Maliekel, K., Rana, N., & Green, D. (1997). Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia, 3(1), 54-8. https://doi.org/10.1046/j.1365-2516.1997.00075.x
Maliekel, K, et al. "Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia." Haemophilia : the official journal of the World Federation of Hemophilia vol. 3,1 (1997): 54-8. doi: https://doi.org/10.1046/j.1365-2516.1997.00075.x
Maliekel K, Rana N, Green D. Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia. Haemophilia. 1997 Jan;3(1):54-8. doi: 10.1046/j.1365-2516.1997.00075.x. PMID: 27214621.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1213 entries